Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Word on the street at the J.P. Morgan Healthcare Conference 2024

2024年1月17日
In-depth analysis

作者

点击此处了解更多
酒店与休闲

Advising gene therapy company AlveoGene on its complex spinout and launch investment

2023年10月23日

作者

点击此处了解更多
公司/并购与资本市场

Advising Lingotto-led investors on chip developer Optalysys Series A funding

2023年7月24日

作者

点击此处了解更多
游戏业务团队

Advising BITKRAFT Ventures on its investment in Scriptic

2023年7月3日

作者 Richard Faichney 以及 Ross McNaughton

点击此处了解更多

与我会面: